CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Aurora Cannabis management commentary cites higher adjusted SG&A as driver of Q2 fiscal 2027 adjusted EBITDA decline

By Public Technologies
  • Aurora Cannabis management commentary attributed second-quarter fiscal 2027 adjusted EBITDA's decline to $14 million from $15.4 million to higher selling costs.
  • International medical cannabis net revenue rose to $61.4 million, driven by stronger patient demand in Germany and Poland.
  • Canadian medical cannabis net revenue fell to $21.2 million as reimbursement cuts reduced revenue; medical adjusted gross margin narrowed to 62%.
  • Net loss from continuing operations narrowed to $21.1 million from $27.2 million, primarily reflecting prior-year impairments and higher gross profit.
  • Free cash outflow decreased to $17.5 million from $39.9 million, primarily reflecting lower working capital investment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070546), on November 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk